Page 324 - Read Online

Shen et al. Evaluation of microRNAs normalization approaches

tissues. Gene 2013;527:26-32. tumor growth and metastasis by targeting CYLD in hepatocellular
44. Wojcicka A, Swierniak M, Kornasiewicz O, Gierlikowski W, Maciag carcinoma. Cancer Lett 2015;356:809-18.
M, Kolanowska M, Kotlarek M, Gornicka B, Koperski L, Niewinski 52. Wylie D, Shelton J, Choudhary A, Adai AT. A novel mean-centering
G, Krawczyk M, Jazdzewski K. Next generation sequencing reveals method for normalizing microRNA expression from high-throughput
microRNA isoforms in liver cirrhosis and hepatocellular carcinoma. RT-qPCR data. BMC Res Notes 2011;4:555.
Int J Biochem Cell Biol 2014;53:208-17. 53. El-Halawany MS, Ismail HM, Zeeneldin AA, Elfiky A, Tantawy
45. Li J, Fu H, Xu C, Tie Y, Xing R, Zhu J, Qin Y, Sun Z, Zheng X. M, Kobaisi MH, Hamed I, Abdel Wahab AH. Investigating the
miR-183 inhibits TGF-beta1-induced apoptosis by downregulation pretreatment miRNA expression patterns of advanced hepatocellular
of PDCD4 expression in human hepatocellular carcinoma cells. BMC carcinoma patients in association with response to TACE treatment.
Cancer 2010;10:354. Biomed Res Int 2015;2015:649750.
46. Li J, Wang Y, Yu W, Chen J, Luo J. Expression of serum miR-221 54. Du C, Lv Z, Cao L, Ding C, Gyabaah OA, Xie H, Zhou L, Wu J,
in human hepatocellular carcinoma and its prognostic significance. Zheng S. MiR-126-3p suppresses tumor metastasis and angiogenesis
Biochem Biophys Res Commun 2011;406:70-3. of hepatocellular carcinoma by targeting LRP6 and PIK3R2. J Transl
47. He XX, Guo AY, Xu CR, Chang Y, Xiang GY, Gong J, Dan ZL, Tian Med 2014;12:259.
DA, Liao JZ, Lin JS. Bioinformatics analysis identifies miR-221 as a 55. Ghosh A, Ghosh A, Datta S, Dasgupta D, Das S, Ray S, Gupta S,
core regulator in hepatocellular carcinoma and its silencing suppresses Datta S, Chowdhury A, Chatterjee R, Mohapatra SK, Banerjee S.
tumor properties. Oncol Rep 2014;32:1200-10. Hepatic miR-126 is a potential plasma biomarker for detection of
48. Sohn W, Kim J, Kang SH, Yang SR, Cho JY, Cho HC, Shim SG, hepatitis B virus infected hepatocellular carcinoma. Int J Cancer
Paik YH. Serum exosomal microRNAs as novel biomarkers for 2016;138:2732-44.
hepatocellular carcinoma. Exp Mol Med 2015;47:e184. 56. Ebrahimi F, Gopalan V, Smith RA, Lam AK. miR-126 in human
49. Pineau P, Volinia S, McJunkin K, Marchio A, Battiston C, Terris cancers: clinical roles and current perspectives. Exp Mol Pathol
B, Mazzaferro V, Lowe SW, Croce CM, Dejean A. miR-221 2014;96:98-107.
overexpression contributes to liver tumorigenesis. Proc Natl Acad Sci 57. Yanokura M, Banno K, Iida M, Irie H, Umene K, Masuda K,
U S A 2010;107:264-9. Kobayashi Y, Tominaga E, Aoki D. MicroRNAS in endometrial
50. Shen H, Li W, Tian Y, Xu P, Wang H, Zhang J, Li Y. Upregulation cancer: recent advances and potential clinical applications. EXCLI J
of miR-362-3p modulates proliferation and anchorage-independent 2015;14:190-8.
growth by directly targeting Tob2 in hepatocellular carcinoma. J Cell 58. Hu L, Ai J, Long H, Liu W, Wang X, Zuo Y, Li Y, Wu Q, Deng
Biochem 2015;116:1563-73. Y. Integrative microRNA and gene profiling data analysis reveals
51. Ni F, Zhao H, Cui H, Wu Z, Chen L, Hu Z, Guo C, Liu Y, Chen Z, novel biomarkers and mechanisms for lung cancer. Oncotarget
Wang X, Chen D, Wei H, Wang S. MicroRNA-362-5p promotes 2016;7:8441-54.

Hepatoma Research ¦ Volume 2 ¦ November 18, 2016 315